1887

Abstract

Summary: Several mechanisms have been described to explain the resistance of cells to methotrexate (MTX); however, the basis for the heterogeneity of mechanisms has been obscure. It was hypothesized that the type of MTX resistance in a single species can be influenced by the form of extracellular folate supplied during the development of resistance. Two strains of MTX-resistant were developed by transferring the bacteria to media containing increasing concentrations of MTX in the presence of constant concentrations of either 5-formyl-5,6,7,8-tetrahydropteroylglutamic acid (5-HCO-HPteGlu) or pteroylglutamic acid (PteGlu). These resistant strains were designated /MTX/5-HCO-HPteGlu and /MTX/PteGlu, respectively. The mechanisms of MTX resistance included: (1) increased folic acid reductase (FAR) activity in both resistant strains but increased dihydrofolate reductase (DHFR) activity only in /MTX/PteGlu; (2) decreased synthesis and intracellular retention of MTX containing two glutamyl residues; (3) decreased uptake of MTX accompanied by decreased uptake of folates; and (4) reduction of folate-binding capacity. Among these, the form of folate present in the media during the development of resistance affected DHFR and FAR activities and the transport of folates. These findings, together with data from other laboratories, suggest that it may be important to use a reduced form of folate, a more physiological form than oxidized PteGlu, in the media during the development of resistance for the study of the mechanisms of MTX resistance in cultured cells.

Loading

Article metrics loading...

/content/journal/micro/10.1099/00221287-143-8-2639
1997-08-01
2021-08-04
Loading full text...

Full text loading...

/deliver/fulltext/micro/143/8/mic-143-8-2639.html?itemId=/content/journal/micro/10.1099/00221287-143-8-2639&mimeType=html&fmt=ahah

References

  1. Alt F. W., Kellems R. E., Schimke R. T. 1976; Synthesis and degradation of folate reductase in sensitive and methotrexate-resistant lines of S-180 cells. J Biol Chem 251:3063–3074
    [Google Scholar]
  2. Antony A. C. 1996; Folate receptors. Annu Rev Nutr 16:501–521
    [Google Scholar]
  3. Blakley R. L. 1969; Absorption spectra of folate derivatives. . In The Biochemistry of Folic Acid and Related Pteridines pp. 91–95 Amsterdam: North-Holland;
    [Google Scholar]
  4. Blakley R. L. 1984; Dihydrofolate reductase. In Folates and Pterins 1Chemistry and Biochemistry of Folates pp. 191–253 Edited by Blakley R. L., Benkovic S. J. New York: Wiley;
    [Google Scholar]
  5. Franklin A. L., Belt M., Stokstad E. L. R., Jukes T. H. 1949; Biological studies with 4-amino-10-methylpteroylglutamic acid. J Biol Chem 177:621–629
    [Google Scholar]
  6. Futterman S. 1963; Preparation and properties of dihydrofolic acid. Methods Enzymol 6:801–802
    [Google Scholar]
  7. Haber D. A., Beverley S. M., Kiely M. L., Schimke R. T. 1981; Properties of an altered dihydrofolate reductase encoded by amplified genes in cultured mouse fibroblasts. J Biol Chem 256:9501–9510
    [Google Scholar]
  8. Hakala M. T., Zakrzewski S. F., Nichol C. A. 1961; Relation of folic acid reductase to amethopterin resistance in cultured mammalian cells. J Biol Chem 236:952–958
    [Google Scholar]
  9. Halpern R. M., Halpern B. C., Clark B. R., Ashe H., Hardy D. N., Jenkinson P. Y., Chou S.-C., Smith R. A. 1975; New approach to antifolate treatment of certain cancers as demonstrated in tissue culture. Proc Natl Acad Sci USA 72:4018–4022
    [Google Scholar]
  10. Houghton P. J., Rahman A., Will C. L., Dolnick B. J., Houghton J. A. 1992; Mutation(s) of the thymidylate synthase gene of human adenocarcinoma cells causes a thymidylate synthase-negative phenotype that can be attenuated by exogenous folates. Cancer Res 52:558–565
    [Google Scholar]
  11. Hutchison D. J. 1957; Metabolism of resistant mutants of Streptococcus faecalis. I. Isolation and characterization of the mutants. Cancer Res 18:214–219
    [Google Scholar]
  12. Jansen G., Westerhof G. R., Jarmuszewski M. J. A., Kathmann I., Rijksen G., Schornagel J. H. 1990; Methotrexate transport in variant human CCRF-CEM leukemia cells with elevated levels of the reduced folate carrier. J Biol Chem 265:18272–18277
    [Google Scholar]
  13. Jolivet J., Schilsky R. L., Bailey B. D., Drake J. C., Chabner B. A. 1982; Synthesis, retention, and biological activity of methotrexate polyglutamates in cultured human breast cancer cells. J Clin Invest 70:351–360
    [Google Scholar]
  14. Krumdieck C. L., Baugh C. M. 1969; The solid-phase synthesis of polyglutamates of folic acid. Biochemistry 8:1568–1572
    [Google Scholar]
  15. Krumdieck C. L., Baugh C. M. 1970; Radioactivie assay of folic acid polyglutamate conjugase (s). Anal Biochem 35:123–129
    [Google Scholar]
  16. van der Laan B. F. A., M., Jansen G., Kathmann I., Schornagel J. H., Hordijk G. J. 1991a; Mechanisms of acquired resistance to methotrexate in a human squamous carcinoma cell line of the head and neck, exposed to different treatment schedules. Eur J Cancer 27:1274–1278
    [Google Scholar]
  17. van der Laan B. F. A., M., Jansen G., van Gestel J. A., Schornagel J. H., Hordijk G. J. 1991b; Membrane transport of methotrexate in a squamous carcinoma cell line adapted to low folate concentrations. Anticancer Res 11:1265–1268
    [Google Scholar]
  18. Leichter J., Butterworth C. E. Jr, Krumdieck C. L. 1977; Partial purification and some properties of pteroylpolyglutamate hydrolase (conjugase) from chicken pancreas. Proc Soc Exp Biol Med 154:98–101
    [Google Scholar]
  19. Miyachi H., Takemura Y., Ando Y., Scanlon K.J. 1992; The role of folates in the development of methotrexate resistance in human leukemia cell line K562. J Cancer Res Clin Oncol 119:101–105
    [Google Scholar]
  20. Nixon P. F., Blakley R. L. 1968; Dihydrofolate reductase of Streptococcus faecium. II. Purification and some properties of two dihydrofolate reductases from the amethopterin-resistant mutant, Streptococcus faecium var. durans strain A. J Biol Chem 243:4722–4731
    [Google Scholar]
  21. Prescott L. M., Affronti L. F. 1968; Presence of conjugase activity in amethopterin-resistant Streptococcus faecium. . J Bacteriol 95:2422–2423
    [Google Scholar]
  22. Rothenberg S. P. 1965; A radioassay for folic acid reductase. Anal Biochem 13:530–543
    [Google Scholar]
  23. Roy K., Mitsugi K., Sirlin S., Shane B., Sirotnak F. M. 1995; Different antifolate-resistant L1210 cell variants with either increased or decreased folylpolyglutamate synthetase gene expression at the level of mRNA transcription. J Biol Chem 270:26918–26922
    [Google Scholar]
  24. Saikawa Y., Knight C. B., Saikawa T., Page S. T., Chabner B. A., Elwood P. C. 1993; Decreased expression of the human folate receptor mediates transport-defective methotrexate resistance in KB cells. J Biol Chem 268:5293–5301
    [Google Scholar]
  25. Schweitzer B. I., Dicker A. P., Bertino J. R. 1990; Dihydrofolate reductase as a therapeutic target. FASEB J 4:2441–2452
    [Google Scholar]
  26. Shen D.-W., Fojo A., Roninson I. B., Chin J. E., Soffir R., Pastan I., Gottesman M. M. 1986; Multidrug resistance of DNA-mediated transformants is linked to transfer of the human mdr1 gene. Mol Cell Biol 6:4039–4044
    [Google Scholar]
  27. Shin Y. S., Buehring K. U., Stokstad E. L. R. 1974; The mechanism of methotrexate in Lactobacillus casei and rat liver and the influence of methotrexate on metabolism of folic acid. J Biol Chem 249:5772–5777
    [Google Scholar]
  28. Smith P. K., Krohn R. I., Hermanson G. T., Mallia A. K., Gartner F. H., Provenzano M. D., Fujimoto E. K., Goeke N. M., Olson B. J., Klenk D. C. 1985; Measurement of protein using bicinchoninic acid. Anal Biochem 150:76–85
    [Google Scholar]
  29. Sur P., Priest D. G., Doig M. T. 1986; Effects of growth rate and methotrexate on folate polyglutamates and folylpolyglutamate hydrolase activity in Krebs ascites cells. Biochem Cell Biol 64:363–367
    [Google Scholar]
  30. Tamura T. 1990; Microbiological assay of folates. . In Folic Acid Metabolism in Health and Disease , pp. 121–137 . Edited by Picciano M. F., Stokstad E. L. R., Gregory J. F. III New York: Wiley-Liss;
    [Google Scholar]
  31. Tamura T., Baggott J. E., Freeberg L. E. 1992; Dihydrofolate reductase and folate reductase in trimetrexate resistant Streptococcus faecium. . In Pteridines and Related Biogenic Amines and Folates , 1992, pp. 260–264 . Edited by Blau N., Curtius H. C., Levine R., Yim J. Souel: Hanrim Publishing;
    [Google Scholar]
  32. van der Veer L. J., Westerhof G. R., Rijksen G., Schornagel J. H., Jansen G. 1989; Cytotoxicity of methotrexate and trimetrexate and its reversal by folinic acid in human leukemic CCRF-CEM cells with carrier-mediated and receptor-mediated folate uptake. Leukemia Res 13:981–987
    [Google Scholar]
  33. Verma R. S., Antony A. C. 1991; Kinetic analysis, isolation, and characterization of hydrophilic folate-binding proteins released from chorionic villi cultured under serum-free conditions. J Biol Chem 266:12522–12535
    [Google Scholar]
  34. Whitehead V. M., Perrault M. M., Stelcner S. 1975; Tissue-specific synthesis of methotrexate polyglutamates in the rat. Cancer Res 35:2985–2990
    [Google Scholar]
http://instance.metastore.ingenta.com/content/journal/micro/10.1099/00221287-143-8-2639
Loading
/content/journal/micro/10.1099/00221287-143-8-2639
Loading

Data & Media loading...

This is a required field
Please enter a valid email address
Approval was a Success
Invalid data
An Error Occurred
Approval was partially successful, following selected items could not be processed due to error